Reports Search Total = 1027

Orthopedic Prosthetics Market – Growth, Trends, and Forecast (2019 – 2024)

Healthcare Published by: Mordor Intelligence Market: Global
113 pages Published: 23-07-2019
  • Healthcare
  • Mordor Intelligence
  • Global
  • 113 pages
  • Published: 23-07-2019

Market Overview

 

The orthopedic prosthetics market is expected to witness a CAGR of 5.4% during the forecast period. Certain factors that are driving the market growth include an increasing number of trauma cases and accidental injuries, technological advancements, and rising prevalence of osteosarcoma.

 

According to the US Department of Health and Human Services, around 8.6 million sports and recreation injuries were reported in 2016 in the United States. Out of these, 72% were injuries related to lower and upper extremities. The injuries are increasing at a rapid rate and are a major factor for the growth of the orthopedic prosthetics market. However, the high cost of prosthetic devices is expected to hinder the market growth. According to the Bioengineering Institute Center for Neuroprosthetics, at the Worcester Polytechnic Institute, a basic below-the-knee prosthetic that would allow a patient to walk on flat ground costs USD 5,000-7,000, while the advanced ones can cost up to USD 20,000 or more. The high cost of the devices and lack of reimbursement policies are considered as the major restraining factors for the orthopedic prosthetics market. The other factor, which is the regulatory requirement is also restraining the growth of the orthopedic prosthetics market.

 

Scope of the Report

 

Orthopedic prosthetics is concerned with the identification, designing, and manufacturing of custom-made artificial limbs in a patient. The devices should be of high strength and low weight. Hence, materials, such as thermoplastics, metals, carbon fiber, EVA (Ethylene-vinyl acetate), or a combination of these are commonly used for production. These devices are used to replace a damaged or missing body part caused by trauma, disease, or other medical conditions. In recent years, the market for orthopedic prosthetics has witnessed significant developments in designing and production technologies. The products have an increased level of comfort, usability, and increased resistance to wear and tear. The vast advances in the CAD/CAM technology and material science have helped in the growth of the market.

 

Key Market Trends

 

Electric-Powered Prosthetics are Expected to Hold Significant Market Share in the Technology Type

 

For amputees, being fitted for a limb prosthesis is definitely a significant first footstep to recovery and regaining independence. However, one important decision patients need to make regarding a prosthetic limb is choosing between an electric or body-powered prosthesis. Electric prostheses, also commonly known as myoelectric prostheses, are controlled using electric signals which are actually created by the body muscles. Specifically, these electric-powered prosthetics work by using the user’s existing muscles in the residual limb in order to control the functions of the prosthetic device itself. A sensor present within the device is able to obtain electrical signals from these muscles. Then it translates those signals into movements and executes the demands properly. Hence, these have become a great option for those who want a natural-looking prosthesis that utilizes existing nerves for functional use.

 

North America Dominates the Market and Expected to do Same in the Forecast Period

 

The key factors driving the growth of the market in North America include the direct presence of key regional players, strong distribution network, and well-established healthcare infrastructure. Recent trends in the North American orthopedic prosthetics market include the use of new polymer material and development of prosthetic device as per the functional need of patients. Manufacturers are concentrating on developing lightweight, yet highly long-lasting orthopedic prosthetics to satisfy the needs of the users.

 

Competitive Landscape

 

The orthopedic prosthetics market is highly competitive and consists of several major players. Companies like Zimmer Biomet Inc., Blatchford Ltd, Bock Healthcare Gmbh, DePuy Synthes, Fillauer LLC, Ohio Willow Wood Co., Smith and Nephew PLC, Stryker Corporation, Touch Bionics Inc., among others, hold the substantial market share in the orthopedic prosthetics market.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Number of Trauma Cases and Accidental Injuries

4.2.2 Technological Advancements

4.2.3 Rising Prevalence of Osteosarcoma

4.3 Market Restraints

4.3.1 Lack of Proper Reimbursement Policies

4.3.2 High Cost of Prosthetic Devices

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 Product

5.1.1 Upper Extremity Prosthetics

5.1.2 Lower Extremity Prosthetics

5.1.3 Sockets

5.1.4 Other Products

5.2 Technology

5.2.1 Conventional

5.2.2 Electric-Powered

5.2.3 Hybrid Orthopaedic Prosthetics

5.3 End User

5.3.1 Hospitals

5.3.2 Prosthetic Centers

5.3.3 Other End Users

5.4 Geography

5.4.1 North America

5.4.1.1 US

5.4.1.2 Canada

5.4.1.3 Mexico

5.4.2 Europe

5.4.2.1 Germany

5.4.2.2 UK

5.4.2.3 France

5.4.2.4 Italy

5.4.2.5 Spain

5.4.2.6 Rest of Europe

5.4.3 Asia-Pacific

5.4.3.1 China

5.4.3.2 Japan

5.4.3.3 India

5.4.3.4 Australia

5.4.3.5 South Korea

5.4.3.6 Rest of Asia-Pacific

5.4.4 Middle East & Africa

5.4.4.1 GCC

5.4.4.2 South Africa

5.4.4.3 Rest of Middle East & Africa

5.4.5 South America

5.4.5.1 Brazil

5.4.5.2 Argentina

5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Blatchford Ltd

6.1.2 Bock Healthcare Gmbh

6.1.3 DePuy Synthes

6.1.4 Fillauer LLC

6.1.5 Ohio Willow Wood Co.

6.1.6 Smith And Nephew PLC

6.1.7 Stryker Corporation

6.1.8 Touch Bionics Inc.

6.1.9 Zimmer Biomet

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

Product

Upper Extremity Prosthetics

Lower Extremity Prosthetics

Sockets

Other Products

 

Technology

Conventional

Electric-Powered

Hybrid Orthopaedic Prosthetics

 

End User

Hospitals

Prosthetic Centers

Other End Users

 

Geography

North America

US

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Asia-Pacific

China

Japan

India

Australia

South Korea

Rest of Asia-Pacific

Middle East & Africa

GCC

South Africa

Rest of Middle East & Africa

South America

Brazil

Argentina

Rest of South America

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Orthobiologics Market – Growth, Trends, and Forecast (2019-2024)

Healthcare Published by: Mordor Intelligence Market: Global
115 pages Published: 23-07-2019
  • Healthcare
  • Mordor Intelligence
  • Global
  • 115 pages
  • Published: 23-07-2019

Market Overview

 

The orthobiologics market was valued at USD 4,747.1 million in 2018 and is expected to reach USD 5,983.82 million by 2024, with an anticipated CAGR of 4.92% during the forecast period (2019-2024).

 

The major factors attributing to the growth of the orthobiologics market are increased incidences of sports injury, road accidents, and osteoarthritis, rising obese and geriatric population, and increasing adoption of minimally invasive surgeries. The global increase in the number of geriatrics and obese people is likely to lead to consequences, like greater incidences of osteoarthritis. Consequently, the geriatric population and population with obesity are at higher risk of musculoskeletal disorders. According to the United Nations report in 2017, there were an estimated 962 million people aged 60 or over in the world, comprising 13% of the global population. The population aged 60 or above is growing at a rate of about 3% per year. It was estimated that Europe had the highest percentage of the population aged 60 or over in 2017. Thus, the rise in geriatric and obese population is acting as a major driver for the growth of orthobiologics market.

 

Scope of the Report

 

Orthobiologics are used by orthopedic surgeons to help injuries heal more quickly. They are used to quicken the healing of broken bones and injured muscles, tendons, and ligaments. These products are made from substances that are naturally found in our body.

 

Key Market Trends

 

Osteoarthritis and Degenerative Arthritis Segment, by Application, is Expected to Experience the Fastest Growth in the Market

 

Osteoarthritis (OA) is a weakening disease that affects 20% of the world’s population, according to the United Nations in 2017. Nearly 130 million are estimated to suffer from OA, out of which 40 million are estimated to be severely disabled by the disease. According to the Arthritis Foundation in 2017, an estimated 30.8 million adults are suffering from osteoarthritis. It is the most common cause of disability in adults.

 

Due to the increasing prevalence of OA, there is an urgent need for better understanding of the disease pathophysiology, improved early detection, strategies for disease prevention, and early management. Orthobiologics can be one such option for the treatment of OA. According to the American Academy of Orthopaedic Surgeons (AAOS), orthobiologics are biological substances found naturally in the body that help to heal injuries. These treatments include platelet-rich plasma (PRP), prolotherapy, ozone therapy, autologous conditioned serum (ACS), and many others. With the increasing prevalence of OA, as well as the development of innovative products, the market growth is expected to be augmented.

 

North America Dominates the Market and Expected to do Same in the Forecast Period

 

North America is expected to dominate the overall market throughout the forecast period. This is due to the increasing incidences of spinal disorders, rising geriatric and obese population, growing preference for minimally invasive procedures, and increasing physician and patient awareness about newly introduced treatment procedures and technologies. In the North American region, the United States holds the largest market share.

 

Competitive Landscape

 

The orthobiologics market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. With the rising patient awareness levels and high prevalence of diseases, few other smaller players are expected to enter into the market in the coming years. Some of the major players of the market are Sanofi, Stryker, Zimmer Biomet, Seaspine Holdings Corporation, and Medtronic, among others.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Incidences of Sports Injuries and Road Accidents

4.2.2 Increasing Incidence of Osteoarthritis

4.2.3 Increasing Geriatric and Obese Population

4.2.4 Increasing Patient Preference for Minimally Invasive Procedures

4.3 Market Restraints

4.3.1 High Costs Associated with Orthobiologic-based Treatments

4.3.2 Preference for Alternative Treatment Options

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Products

5.1.1 Viscosupplementation Products

5.1.2 Demineralized Bone Matrices

5.1.3 Synthetic Orthobiologics

5.1.4 Bone Morphogenic Protein

5.1.5 Allografts

5.1.6 Plasma-rich Protein

5.1.7 Bone Marrow Aspirate Concentrate

5.2 By Application

5.2.1 Osteoarthritis and Degenerative Arthritis

5.2.2 Spinal Fusion

5.2.3 Soft-tissue Injuries

5.2.4 Fracture Recovery

5.2.5 Maxillofacial and Dental Applications

5.3 By End User

5.3.1 Hospitals, Orthopedic Clinics, and Ambulatory Care Centers

5.3.2 Research and Academic Institutes

5.3.3 Dental Clinics and Facilities

5.4 Geography

5.4.1 North America

5.4.1.1 US

5.4.1.2 Canada

5.4.1.3 Mexico

5.4.2 Europe

5.4.2.1 Germany

5.4.2.2 UK

5.4.2.3 France

5.4.2.4 Italy

5.4.2.5 Spain

5.4.2.6 Rest of Europe

5.4.3 Asia-Pacific

5.4.3.1 China

5.4.3.2 Japan

5.4.3.3 India

5.4.3.4 Australia

5.4.3.5 South Korea

5.4.3.6 Rest of Asia-Pacific

5.4.4 Middle East & Africa

5.4.4.1 GCC

5.4.4.2 South Africa

5.4.4.3 Rest of Middle East & Africa

5.4.5 South America

5.4.5.1 Brazil

5.4.5.2 Argentina

5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Arthrex Inc.

6.1.2 Sanofi

6.1.3 DePuy Synthes (A Subsidiary of Johnson & Johnson)

6.1.4 Globus Medical Inc.

6.1.5 Terumo Corporation

6.1.6 Stryker Corporation

6.1.7 Zimmer Biomet

6.1.8 Medtronic PLC

6.1.9 NuVasive Inc.

6.1.10 Integra Lifesciences

6.1.11 Bone Support

6.1.12 Seaspine Holdings Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

By Products

Viscosupplementation Products

Demineralized Bone Matrices

Synthetic Orthobiologics

Bone Morphogenic Protein

Allografts

Plasma-rich Protein

Bone Marrow Aspirate Concentrate

 

By Application

Osteoarthritis and Degenerative Arthritis

Spinal Fusion

Soft-tissue Injuries

Fracture Recovery

Maxillofacial and Dental Applications

 

By End User

Hospitals, Orthopedic Clinics, and Ambulatory Care Centers

Research and Academic Institutes

Dental Clinics and Facilities

 

Geography

North America

US

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Asia-Pacific

China

Japan

India

Australia

South Korea

Rest of Asia-Pacific

Middle East & Africa

GCC

South Africa

Rest of Middle East & Africa

South America

Brazil

Argentina

Rest of South America

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Orphan Drugs Market – Growth, Trends, and Forecast (2019-2024)

Healthcare Published by: Mordor Intelligence Market: Global
114 pages Published: 23-07-2019
  • Healthcare
  • Mordor Intelligence
  • Global
  • 114 pages
  • Published: 23-07-2019

Market Overview

 

The orphan drugs market is expected to register a CAGR of 11.5% over the forecast period. Factors that are responsible for the growth of this market include market exclusivity for orphan drug developers, the rising prevalence of rare diseases, and favorable government policies.

 

The market is expected to register an increased CAGR during the forecast period because the prevalence of rare diseases among the global population has been increasing in recent years. To tackle this issue, both developing and developed countries have formulated regulations that promote the development of drugs for rare diseases, as well as make sure that these drugs are easily available to the patients. Currently, the average approval time for non-orphan drugs is around 13 months and the same for orphan drugs is much less at around 10 months. The European Union has implemented similar policies for the development of these drugs and the European governments have individually implemented these policies in their countries. Some of these are Italy’s AIFA 5% Fund, Belgium’s Special Solidarity Fund, and France’s Temporary Authorizations for use. Even the countries in Asia-Pacific have also followed similar steps with countries like Japan, South Korea, and Taiwan with initiatives like the Revised Orphan Drug Regulations and Orphan Drugs Guidelines (2003). These initiatives offered tax credits and subsidies to both the patient as well as the pharmaceutical companies. These policies in various countries around the world have evolved the market studied, that has been growing at a healthy rate in recent years.

 

Scope of the Report

 

Orphan drugs can be defined as a molecule intended to treat a rare disease. The rare disease, as the name suggests, has a low prevalence rate and has been defined differently across geographical locations.

 

Key Market Trends

 

Biological Orphan Drug is Expected to Account for the Highest Market Share

 

In the type of drug segment, biological orphan drug may register the highest market share and is expected to grow at a good pace, during the forecast period. This high market share is due to the higher cost of biological drugs compared to non-biological ones. The recent trend of approval of biological orphan drugs for multiple indication has resulted in growth and has been an encouraging factor for new and established market players to enter in this market. Another reason is that the biological drugs have been used for treating rare disease for a long time. The most focused orphan disease, i.e., cancer, which has a higher prevalence rate in the developed world, has been effectively treated by biological drugs with fewer side effects.

 

North America Dominates the Market and Expected to do the same in the Forecast Period

 

North America currently dominates the market for orphan drugs and is expected to continue its stronghold for a few more years. In the North American region, the United States holds the largest market share. One of the reasons for market growth is that in the United States, a drug designated orphan drug status receives seven years of marketing exclusivity upon FDA approval for a specific indication, tax credits, and user fee waiver. Since 2013, the new indication approvals have increased greatly.

 

Competitive Landscape

 

The orphan drugs market is moderately competitive and consists of quite a few major players. In terms of market share, a few of the major players currently dominate the market. With the rising number of diseases and an increasing number of cases each year, a few smaller players are entering the market and holding a substantial share. Some of the major players of the market are Teva Pharmaceutical Industries Ltd, Celgene, Merck & Co. Inc., Bristol-Myers Squibb Company, and F. Hoffmann-La Roche AG, among others.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Market Exclusivity for Orphan Drug Developers

4.2.2 Rising Prevalence of Rare Diseases

4.2.3 Favorable Government Policies

4.3 Market Restraints

4.3.1 High Per Patient Treatment Cost

4.3.2 Limited Patient Pool for Clinical Trials and Product Marketing

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Drug Type

5.1.1 Biological

5.1.2 Non-Biological

5.2 By Top Selling Drugs

5.2.1 Revlimid

5.2.2 Rituxan

5.2.3 Copaxone

5.2.4 Opdivo

5.2.5 Keytruda

5.2.6 Imbruvica

5.2.7 Avonex

5.2.8 Sensipar

5.2.9 Soliris

5.2.10 Other Top Selling Drugs

5.3 By Disease Type

5.3.1 Oncology

5.3.2 Hematology

5.3.3 Neurology

5.3.4 Cardiovascular

5.3.5 Other Disease Types

5.4 By Phase

5.4.1 Phase I

5.4.2 Phase II

5.4.3 Phase III

5.4.4 Phase IV

5.5 Geography

5.5.1 North America

5.5.1.1 US

5.5.1.2 Canada

5.5.1.3 Mexico

5.5.2 Europe

5.5.2.1 Germany

5.5.2.2 UK

5.5.2.3 France

5.5.2.4 Italy

5.5.2.5 Spain

5.5.2.6 Rest of Europe

5.5.3 Asia-Pacific

5.5.3.1 China

5.5.3.2 Japan

5.5.3.3 India

5.5.3.4 Australia

5.5.3.5 South Korea

5.5.3.6 Rest of Asia-Pacific

5.5.4 Middle East & Africa

5.5.4.1 GCC

5.5.4.2 South Africa

5.5.4.3 Rest of Middle East & Africa

5.5.5 South America

5.5.5.1 Brazil

5.5.5.2 Argentina

5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 AbbVie

6.1.2 Celgene Corporation

6.1.3 Biogen

6.1.4 Teva Pharmaceutical Industries

6.1.5 F. Hoffmann-La Roche AG

6.1.6 Bristol-Myers Squibb Company

6.1.7 Alexion Pharmaceuticals

6.1.8 Amgen

6.1.9 Merck & Co. Inc.

6.1.10 Jazz Pharmaceuticals

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

By Drug Type

Biological

Non-Biological

 

By Top Selling Drugs

Revlimid

Rituxan

Copaxone

Opdivo

Keytruda

Imbruvica

Avonex

Sensipar

Soliris

Other Top Selling Drugs

 

By Disease Type

Oncology

Hematology

Neurology

Cardiovascular

Other Disease Types

 

By Phase

Phase I

Phase II

Phase III

Phase IV

 

Geography

North America

US

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Asia-Pacific

China

Japan

India

Australia

South Korea

Rest of Asia-Pacific

Middle East & Africa

GCC

South Africa

Rest of Middle East & Africa

South America

Brazil

Argentina

Rest of South America

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Pediatric Vaccines Market – Growth, Trends, and Forecast (2019 – 2024)

Healthcare Published by: Mordor Intelligence Market: Global
116 pages Published: 23-07-2019
  • Healthcare
  • Mordor Intelligence
  • Global
  • 116 pages
  • Published: 23-07-2019

Market Overview

 

The global pediatric vaccine market is expected to register 11.7% CAGR during the forecast period 2019-2024. The growth of the pediatric vaccines market is attributed due to the rising burden of chronic disease with the importance and awareness of immunization, technological advancements in vaccines, an increase in the government and non-government funding in R&D.


As immunization plays a significant role in modern medicine, there are several international programs for children, which may vary based on the disease. However, these programs are primarily driving the demand for the pediatric vaccines market.


There are several chronic diseases among children, which make them further susceptible to severe manifestations and complications with chronic diseases, For example, diseases, such as allergic, cardiorespiratory, hematologic, metabolic, and renal disorders, among others, lead to an increased risk of developing influenza, varicella, and pneumococcal infection. The parental understanding regarding these complications and immunization benefits is also required to raise awareness regarding pediatric vaccines. The television, by far, is the most common source of information, followed by health professionals, newspapers, and magazines. The uptake of pediatric vaccination has improved through community-based vaccination program, which communicates the benefits and effectiveness of vaccines, hence promoting the growth of the pediatric vaccines market.


Furthermore, government initiatives, like Vaccines for Children Program, provides vaccines to children who lack health insurance or cannot afford the cost of vaccination, which is funded by the Centers for Medicare and Medicaid Services (CMS) to the Centers for Disease Control (CDC), and approved by the Office of Management and Budget.

 

Scope of the Report

 

As per the scope of the report, pediatric vaccines are vaccines that stimulate the body’s immune response, in order to prevent a specific disease in children.

 

Key Market Trends

 

The Conjugate Vaccine Segment, under Technology, is Expected to Grow at the Fastest Rate, during the Forecast Period

The conjugate vaccine segment held a maximum share in 2018, and is likely to witness a rapid growth during the forecast period, due to the increasing prevalence of pneumococcal and meningococcal infections, and rise in the awareness regarding the prevention of infection, by government initiatives.

 

The North American Region Holds the Largest Market Share of the Pediatric Vaccines Market and is Projected to Follow the Same Trend over the Forecast Period

 

North America is expected to be the primary region for the pediatric vaccines market, over the forecast period. The scheduled children immunization programs under the Centers for Disease Control and Prevention (CDC), high funding, wide commercial availability of vaccines, and the awareness in society regarding vaccines contribute to the sustained growth in the United States. In Canada, the vaccination schedule for infants and children are regularly updated by the Government of Canada, in collaboration with the Canadian Nursing Coalition for Immunization (CNCI) and the Canadian Immunization Committee (CIC). The well-structured healthcare services boost the growth of the pediatric vaccines market in North America.

 

Competitive Landscape

The pediatric vaccines market consists of several major players, including GlaxoSmithKline PLC, Merck & Co. Inc., Novartis AG, etc. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help them in strengthening their market position.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Chronic Diseases with the Importance and Awareness of Immunization
4.2.2 Technological Advancements in Vaccines
4.2.3 Increase in the Government and Non-government Funding in R&D
4.3 Market Restraints
4.3.1 Cost of Immunization
4.3.2 Low Medical Coverage and Healthcare Services in Low- and Middle-income Countries
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Vaccine Type
5.1.1 Monovalent
5.1.2 Multivalent
5.2 By Technology
5.2.1 Live Attenuated
5.2.2 Inactivated
5.2.3 Toxoid
5.2.4 Conjugate
5.2.5 Other Technologies
5.3 By Application
5.3.1 Infectious Disease
5.3.2 Cancer
5.3.3 Allergy
5.3.4 Other Applications
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 GlaxoSmithKline PLC
6.1.2 Indian Immunologicals Limited
6.1.3 AstraZeneca
6.1.4 Merck & Co. Inc.
6.1.5 Mitsubishi Tanabe Pharma Corporation
6.1.6 Novartis AG
6.1.7 Pfizer Inc.
6.1.8 Sanofi SA
6.1.9 Seqirus (CSL Limited)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

 

By Vaccine Type
Monovalent
Multivalent

By Technology
Live Attenuated
Inactivated
Toxoid
Conjugate
Other Technologies

By Application
Infectious Disease
Cancer
Allergy
Other Applications

Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

 

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Oriented Strand Board (OSB) Market – Growth, Trends, and Forecast (2019 – 2024)

Chemical & Materials Published by: Mordor Intelligence Market: Global
125 pages Published: 23-07-2019
  • Chemical & Materials
  • Mordor Intelligence
  • Global
  • 125 pages
  • Published: 23-07-2019

Market Overview

 

The market for oriented strand board is expected to register a CAGR of 6.2%, during the forecast period of 2019-2024. One of the major factors driving the market studied is the growing prominence of OSB, as a substitute to plywood. Emissions of volatile organic compounds (VOCS), like formaldehyde, is expected to hinder the growth of the market studied.

 

The construction industry dominated the market in 2017, and is expected to grow at the fastest rate during the forecast period, owing to the increasing applications, such as floor and roof, walls, etc.

Increasing application of OSB in structural insulated panels is likely to act as an opportunity in the future.

North America dominated the market across the world, with the largest consumption from the United States.

 

Key Market Trends

 

Soaring Demand from the Construction Industry

 

Wood-based panels are crucial to the construction industry, providing high structural durability to roofs and floors, walls, beams, doors, staircase, etc. In OSB panels, they produce a stronger and stiffer panel than other products used in similar types of construction projects. The material eliminates rings and knots, which makes it more uniform. Its structure provides OSB a great deal of strength, alowing to be used in a broad range of applications, particularly for load-bearing applications.

The building and construction industry is currently a thriving industry in several emerging economies of the Asia-Pacific and the South American regions, which is expected to drive the use of OSB, thus minimizing infrastructure failures.

Oriented strand boards are a cost-effective alternative for home construction. As per the National Association of Certified Home Inspectors (NACHI), OSB costs USD 700 less than plywood for a typical 2400-square foot home.

Tiles, plywood, and wooden boards are considered as relatively more expensive than OSB, when it comes to flooring. OSB floors are more suitable than hardwood, as it adds a more natural and decorative effect to the home interior design. Furthermore, the total cost of flooring the entire area with hardwood is quite high.

 

The United States to Dominate the Market

 

The US office space market witnessed slight reduction in growth in 2017, as it experienced a slowdown in tenant expansions, while the overall supply growth remained at about the same level as in 2016. In 2017, an increase of 21 million square feet of office space has been witnessed. This level of “net absorption” is understood to be the lowest since 2012, and is down from 29 million square feet increase from 2016. The usage of OSB in packaging application is on the rise, owing to the growing number of millennial and increasing purchasing power among them. However, packaging application accounts for a small portion in the OSB market. Additionally, the United States is the largest exporter and importer of goods and services, and hugely relies on wood packaging for proper protection of these goods, which is increasing the demand for OSB for packaging in the country.

 

Competitive Landscape

 

The oriented strand board (OSB) market is consolidated in nature, with the top five players accounting for a significant portion in the global market. The major companies include Norbond Inc., Louisiana-Pacific Corporation, Kronospan Ltd, Georgia-Pacific, and Weyerhaeuser Company. 

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Drivers

4.1.1 Desirable Properties

4.1.2 Growing Prominence of OSB, as a Substitute to Plywood

4.2 Restraints

4.2.1 Emissions of Volatile Organic Compounds (VOCS), like Formaldehyde

4.2.2 Other Restraints

4.3 Industry Value-Chain Analysis

4.4 Porters Five Forces Analysis

4.4.1 Bargaining Power of Suppliers

4.4.2 Bargaining Power of Consumers

4.4.3 Threat of New Entrants

4.4.4 Threat of Substitute Products and Services

4.4.5 Degree of Competition

5 MARKET SEGMENTATION

5.1 Grade

5.1.1 OSB/1

5.1.2 OSB/2

5.1.3 OSB/3

5.1.4 OSB/4

5.2 End-user Application

5.2.1 Furniture

5.2.1.1 Residential

5.2.1.2 Commercial

5.2.2 Construction

5.2.2.1 Floor and Roof

5.2.2.2 Wall

5.2.2.3 Door

5.2.2.4 Column and Beam

5.2.2.5 Staircase

5.2.2.6 Other Construction Applications

5.2.3 Packaging

5.2.3.1 Food and Beverage

5.2.3.2 Industrial

5.2.3.3 Pharmaceutical

5.2.3.4 Cosmetics

5.2.3.5 Other Packaging Applications

5.3 Geography

5.3.1 Asia-Pacific

5.3.1.1 China

5.3.1.2 India

5.3.1.3 Japan

5.3.1.4 South Korea

5.3.1.5 Australia & New Zealand

5.3.1.6 Rest of Asia-Pacific

5.3.2 North America

5.3.2.1 United States

5.3.2.2 Canada

5.3.2.3 Mexico

5.3.2.4 Rest of North America

5.3.3 Europe

5.3.3.1 Germany

5.3.3.2 United Kingdom

5.3.3.3 The Netherlands

5.3.3.4 France

5.3.3.5 Italy

5.3.3.6 Spain

5.3.3.7 Rest of Europe

5.3.4 South America

5.3.4.1 Brazil

5.3.4.2 Argentina

5.3.4.3 Rest of South America

5.3.5 Middle East & Africa

5.3.5.1 Saudi Arabia

5.3.5.2 South Africa

5.3.5.3 Rest of Middle East & Africa

6 COMPETITIVE LANDSCAPE

6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements

6.2 Market Share Analysis**

6.3 Strategies Adopted by Leading Players

6.4 Company Profiles

6.4.1 Arbec Forest Products Inc.

6.4.2 Coillte

6.4.3 EGGER Group

6.4.4 Georgia-Pacific Wood Products LLC

6.4.5 Huber Engineered Woods LLC

6.4.6 Kronospan Limited

6.4.7 KronoSwiss

6.4.8 Louisiana-Pacific Corporation

6.4.9 Norbord Inc.

6.4.10 RoyOMartin Lumber Company

6.4.11 Sonae Industria SGPS SA

6.4.12 Tolko Industries Ltd

6.4.13 Weyerhaeuser Company

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

7.1 Increasing Application of OSB in Structural Insulated Panels (SIPs)

MARKET SEGMENTATION

 

Grade

OSB/1

OSB/2

OSB/3

OSB/4

 

End-user Application

Furniture

Residential

Commercial

Construction

Floor and Roof

Wall

Door

Column and Beam

Staircase

Other Construction Applications

Packaging

Food and Beverage

Industrial

Pharmaceutical

Cosmetics

Other Packaging Applications

 

Geography

Asia-Pacific

China

India

Japan

South Korea

Australia & New Zealand

Rest of Asia-Pacific

North America

United States

Canada

Mexico

Rest of North America

Europe

Germany

United Kingdom

The Netherlands

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Saudi Arabia

South Africa

Rest of Middle East & Africa

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type

Optometry Equipment Market – Growth, Trends, and Forecast (2019-2024)

Healthcare Published by: Mordor Intelligence Market: Global
115 pages Published: 23-07-2019
  • Healthcare
  • Mordor Intelligence
  • Global
  • 115 pages
  • Published: 23-07-2019

Market Overview

 

The optometry equipment market is expected to register a CAGR of 5.8% over the forecast period. Factors that are responsible for the growth of this market include the rising prevalence of eye diseases, technological advancements in ophthalmic devices, and increasing government initiatives to control visual impairment.

 

For instance, the total number of persons with visual impairment and blindness is increasing, globally. The number of people with age-related eye diseases is assumed to be on the rise with the increasing life expectancy. Cataract is still the major cause of visual impairment and blindness, globally, but other age-related eye diseases, such as age-related macular degeneration (AMD), glaucoma, diabetic retinopathy (DR), and degenerative myopia, are becoming more popular in the developed countries. Cataract is the most prevalent eye disease in the world and is a major cause of visual loss in the developing as well as the developed countries. A number of risk factors have been suggested for cataract, age-related macular degeneration, and glaucoma, yet only a few have been well established. Hence, as a result of these eye diseases, there is an increase in the adoption of the optometry equipment for treating eye disorders, and thereby, helping in the market growth.

 

Scope of the Report

 

Optometry equipment are used to examine, diagnose, and manage diseases and disorders of the visual system, the eye, and deformities associated with eye structures, as well as to diagnose eye related systemic disorders. The optometry equipment includes a set of equipment used for cornea and cataract examination, as well as retina and glaucoma examination purposes.

 

Key Market Trends

 

OCT Scanner is Expected to Hold the Major Revenue share in the Retina Examination

 

Optical coherent tomography scanner (OCT) is expected to hold the largest revenue share in terms of the retina examination segment. The primary factors attributed for the major revenue is due to the growing prevalence of eye conditions, such as glaucoma and scotoma. These are the key causes that are contributing to the dominance. And according to the National Institute of Health Statistics, in 2017 approximately 2.7 million population in the United States are aged 40 and above had glaucoma in their eyes. And the presence of the well-established healthcare and insurance system is also helping in the growth of the market.

 

North America Dominates the Optometry Equipment Market and Excepted to do Same in the Forecast Period

 

North America currently dominates the market for optometry equipment and is expected to continue its stronghold for a few more years. In the North American region, the United States holds the largest market share. This can be majorly attributed to increasing incidence rates of eye diseases and the rising number of aged population. The presence of the developed healthcare infrastructure is expected to propel the market in the United States.

 

Competitive Landscape

 

The optometry equipment market is moderately competitive and consists of various small and large surgical/medical device manufacturing companies which are offering products for ophthalmic diagnostics and treatments. The market is competitive in nature. It is dominated by participants, such as the Novartis AG (Alcon), Carl Zeiss Meditec AG, Canon Inc., Heidelberg Engineering Inc., and NIDEK CO. LTD, among others.

 

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– Report customization as per the client’s requirements

– 3 months of analyst support

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Rising Prevalence of Eye Diseases

4.2.2 Technological Advancements in Ophthalmic Devices

4.2.3 Increasing Government Initiatives to Control Visual Impairment

4.3 Market Restraints

4.3.1 High Cost of Eye Examination Equipment

4.3.2 Lack of Awareness and Low Accessibility to Eye Care in Low-income Economies

4.4 Porter’s Five Forces Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Type of Examination

5.1.1 Retina  Examination

5.1.1.1 OCT Scanner

5.1.1.2 Fundus Camera

5.1.1.3 Visual Field Analyzer

5.1.1.4 Ophthalmoscope

5.1.1.5 Retinoscope

5.1.2 Cornea  Examination

5.1.2.1 Wavefront Aberrometer

5.1.2.2 Specular Microscope

5.1.2.3 Other Cornea Examinations

5.1.3 General Examination

5.1.3.1 Autorefractor

5.1.3.2 Ophthalmic Ultrasound System

5.1.3.3 Tonometer

5.1.3.4 Phoropter

5.1.3.5 Keratometer

5.1.3.6 Lensometer

5.1.3.7 Other General Examinations

5.2 By End User

5.2.1 Eye Clinic

5.2.2 Hospital

5.2.3 Other End Users

5.3 Geography

5.3.1 North America

5.3.1.1 US

5.3.1.2 Canada

5.3.1.3 Mexico

5.3.2 Europe

5.3.2.1 Germany

5.3.2.2 UK

5.3.2.3 France

5.3.2.4 Italy

5.3.2.5 Spain

5.3.2.6 Rest of Europe

5.3.3 Asia-Pacific

5.3.3.1 China

5.3.3.2 Japan

5.3.3.3 India

5.3.3.4 Australia

5.3.3.5 South Korea

5.3.3.6 Rest of Asia-Pacific

5.3.4 Middle East & Africa

5.3.4.1 GCC

5.3.4.2 South Africa

5.3.4.3 Rest of Middle East & Africa

5.3.5 South America

5.3.5.1 Brazil

5.3.5.2 Argentina

5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Novartis AG (Alcon)

6.1.2 Canon Inc.

6.1.3 CARL ZEISS MEDITEC AG

6.1.4 BAUSCH & LOMB, INC.

6.1.5 ESSILOR INTERNATIONAL S.A.

6.1.6 Johnson & Johnson Vision Care Inc.

6.1.7 Heidelberg Engineering Inc.

6.1.8 HEINE Optotechnik

6.1.9 Luneau Technology Group

6.1.10 NIDEK CO. LTD

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

MARKET SEGMENTATION

 

By Type of Examination

Retina  Examination

OCT Scanner

Fundus Camera

Visual Field Analyzer

Ophthalmoscope

Retinoscope

Cornea  Examination

Wavefront Aberrometer

Specular Microscope

Other Cornea Examinations

General Examination

Autorefractor

Ophthalmic Ultrasound System

Tonometer

Phoropter

Keratometer

Lensometer

Other General Examinations

 

By End User

Eye Clinic

Hospital

Other End Users

 

Geography

North America

US

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Asia-Pacific

China

Japan

India

Australia

South Korea

Rest of Asia-Pacific

Middle East & Africa

GCC

South Africa

Rest of Middle East & Africa

South America

Brazil

Argentina

Rest of South America

We value your investment and offer free customization with every report to fulfil your exact research needs.

Share This Post:

Choose License Type